ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,428, issued on Dec. 16, was assigned to GALECTO BIOTECH AB (Copenhagen, Denmark).
"Galactoside inhibitor of galectins" was invented by Fredrik Zetterberg (Askim, Sweden), Ulf Nilsson (Lund, Sweden), Thomas Brimert (Blentarp, Sweden), Kristoffer Peterson (Lund, Sweden) and Karl Jansson (Lund, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "A compound of the general formula I or II. The compound of formula I or II is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, a method for treatment of a disorder relating to the binding of a ...